Lakeshore Biopharma (LSB) Expected to Announce Earnings on Monday

Lakeshore Biopharma (NASDAQ:LSBGet Free Report) is expected to be issuing its quarterly earnings data before the market opens on Monday, January 27th. Analysts expect the company to announce earnings of ($0.80) per share for the quarter.

Lakeshore Biopharma Price Performance

LSB opened at $2.63 on Friday. The company has a debt-to-equity ratio of 0.13, a current ratio of 1.17 and a quick ratio of 0.90. Lakeshore Biopharma has a 12 month low of $1.88 and a 12 month high of $11.20. The business has a 50 day simple moving average of $2.86 and a 200-day simple moving average of $3.92.

About Lakeshore Biopharma

(Get Free Report)

LakeShore Biopharma Co, Ltd. engages in the provision of discovering, developing, manufacturing, and commercializing vaccines and therapeutic biologics for infectious diseases and cancer. It focuses on developing PIKA technology platform. It operates through the People’s Republic of China and Other Countries or Regions.

Further Reading

Earnings History for Lakeshore Biopharma (NASDAQ:LSB)

Receive News & Ratings for Lakeshore Biopharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lakeshore Biopharma and related companies with MarketBeat.com's FREE daily email newsletter.